At an adjudication by the Marketing Code Authority (MCA), which regulates the local pharmaceutical industry, both Roche and Novartis distanced themselves from the recent statement on intellectual property rights by the Swiss Chamber of Commerce, SwissCham Southern Africa.
18 Mar 2014 13:57
This week it was confirmed that Kaizer Chiefs player, Josta Dladla, tested positive for the banned stimulant, methylhexanamine, commonly known as 1.3-dimethyl or DMAA, the use of which is banned in professional sport.
17 Jan 2014 16:44
It is important for South African consumers to make sure that the pharmaceutical products they purchase are manufactured safely and comply with the necessary standards, as taking unsafe, illegal medicines can have dangerous consequences.
By Manfred Boensch 11 Oct 2013 14:22
One of South Africa's most popular contraceptives, Yasmin, is the subject of a bitter court battle that pits a generic drugs company against a multinational.
10 Oct 2013 12:59
The National Association of Pharmaceutical Manufacturers (NAPM) believes that a switch of 5% of the volume of branded medicines to a generic equivalent could save the healthcare industry and patients in excess of R400-million per year.
26 Sep 2013 15:20
The South African public is starting to embrace the use of generic medicines, a trend that the Department of Health is hoping will continue. The generic medicines industry in South Africa provides cost-effective treatment for a wide range of health conditions, hence the theme for National Pharmacy Week, running from 1 - 8 September 2013, is 'Understanding generic medicines'.
3 Sep 2013 11:47
Sandoz, the generic pharmaceuticals division of Novartis, has launched the first-to-market generic medicine for the treatment of gastro-oesophageal reflux disease (GORD).
28 Aug 2013 17:47
SA skin-care brand Bio-Oil is a worldwide success story, and the core product of Union Swiss, a multi-million dollar company that sells Bio-Oil in over 50 countries worldwide.
26 Aug 2013 15:36
Pfizer together with the South African Depression and Anxiety Group (SADAG) are offering South African media the 'Pfizer Mental Health Journalism Awards for 2013/14.
15 Aug 2013 10:33
The local cost of healthcare in South Africa continues to spiral, as its lax patent regime lags behind international developments, hampering access to affordable treatment. Brazil has moved to crack down on anti-competitive behaviour in the pharmaceutical industry, but there is little promise that local patients will soon benefit from similar interventions.
By Paul Anley 30 Jul 2013 11:20
Bringing its investment over the last 18 months to R1bn, Ascendis Health has acquired Solal Technologies and a majority stake in Marltons for approximately R300m. It has made two appointments in these companies.
15 Jul 2013 10:09
Recent research by risk solutions firm Inoxico into the external directorships of JSE-listed companies showed that the directors of South Africa's 20 largest companies held on average 14 external directorships.
12 Jul 2013 10:15
Despite health insurance often being considered a grudge purchase, private medical aid policyholders in South Africa gave the health insurance industry a satisfaction score of 73 out of 100.
10 Jul 2013 08:37
The National Association of Generic Manufacturers (NAPM) maintains that its members could play a bigger role in reducing the costs of medicines in hospitals. This is in response to the call to the Competition Commission to include the pharmaceutical sector in its investigation into the costs of private healthcare, by two of the larger hospital groups, Netcare and Mediclinic.
By Dr Anban Pillay 11 Jun 2013 11:47
Receive free email newsletter
Tell a friend about us